MLL1 or KMT2A translocations, found in about 5–10% of all adult AML cases, lead to a fusion protein between KMT2A and about 80 different fusion partners, all of which bind to menin at the N- terminus end of KMT2A. Here, KMT2A is linked to acute myeloid leukemia.